title: [Rationale for improved treatment of ulcerative disease complicated by chronic pyelonephritis].
abstract: In summary, to come to objective conclusions as proven treatment that achieved by improvement schemes. Detected somewhat smaller difference in the degree of risk in the treatment of existing and improved schemes ulcer and neasotsiyovanoyi it when the underlying disease complicated by chronic inflammation, in our opinion, due to greater perfection, adapted first for this category of patients, among other options.
authors.forename: T D
authors.initials: TD
authors.lastname: Nykula
authors.forename: V V
authors.initials: VV
authors.lastname: Furleta
mesh_terms: D000368:Aged; D000658:Amoxicillin / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D017291:Clarithromycin / Q000627:therapeutic use*; D004032:Diet; D005260:Female; D016481:Helicobacter Infections / Q000150:complications / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D016480:Helicobacter pylori / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D007668:Kidney / Q000187:drug effects / Q000382:microbiology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis / Q000150:complications / Q000382:microbiology / Q000473:pathology / Q000628:therapy*; D064750:Rabeprazole / Q000627:therapeutic use*; D012307:Risk Factors; D016896:Treatment Outcome; D014456:Ulcer / Q000150:complications / Q000382:microbiology / Q000473:pathology / Q000628:therapy*
chemical_list: D000897:Anti-Ulcer Agents; D064750:Rabeprazole; D000658:Amoxicillin; D017291:Clarithromycin